Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Seattle Genetics Inc (SGEN)

49.68 0.11 (0.22%)

04-20 16:00

Open:

49.44

Pre. Close:

49.57

High:

49.86

Low:

48.98

Volume:

864,966

Market Cap:

7857M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

49.885 - 50.131

50.131 - 50.38

Low:

48.399 - 48.655

48.655 - 48.915

Close:

49.268 - 49.674

49.674 - 50.086

Technical analysis  (as of: 2018-04-20 4:33:32 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 63.79     One year: 67.86

Support:

Support1: 48.98    Support2: 40.75

Resistance:

Resistance1: 54.62    Resistance2: 58.10

Pivot:

50.91

Moving Averages:

MA(5): 50.42     MA(20): 51.17

MA(100): 54.22     MA(250): 56.11

MACD:

MACD(12,26): -1.05     Signal(12,26,9):

%K %D:

%K(14,3): 16.39     %D(3): 24.21

RSI:

RSI(14): 41.01

52-Week:

High: 71.32  Low: 45.31  Change(%): -24.2

Average Vol(K):

3-Month: 111459  10-Days 70439

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SGEN has closed above bottom band by 17.7%. Bollinger Bands are 44.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to SGEN's normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-20T07:43:03-04:00
Key events next week - healthcare

2018-04-17T11:46:21-04:00
JF's Core Biotech Buys #11: Positive News For Several Holdings, A Change To Benchmarks And Introducing Our 17th Position

2018-04-12T08:00:00-04:00
Seattle Genetics Highlights Novel Antibody-Drug Conjugate Technologies and Immuno-Oncology Program Advances at the American Association for Cancer Research (AACR) Annual Meeting

2018-04-10T01:35:52-04:00
JF's Core Biotech Buys #10: Incyte Disappoints, Optimism Returns To Gene Therapy And A New Position

2018-04-05T11:59:38-04:00
BioSci Rounds Report: Unlocking Hidden Values In Omeros, Unum, And Nektar

2018-04-05T08:00:00-04:00
Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter Financial Results on April 26, 2018

2018-04-03T13:10:52-04:00
JF's Core Biotech Buys #9: Shire In Play, Volatility Continues And Capitalizing On Weakness

2018-03-28T08:00:00-04:00
3 Things In Biotech, March 27: Roche Rips, Loxo Rolls, Astellas Rams

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

158.16

Shares Float (M)

155.88

% Held by Insiders

1.40

% Held by Institutions

92.70

Shares Short (K)

14632

Shares Short Prior Month (K)

11890

Stock Financials

EPS

-1.410

EPS Est. Current Year

-1.690

EPS Est. Next Year

-1.230

EPS Est. Next Quarter

-0.420

Forward EPS

-0.570

Book Value (p.s.)

12.050

PEG Ratio

-0.12

Profit Margin

-17.57

Operating Margin

-40.60

Return on Assets (ttm)

-14.6

Return on Equity (ttm)

-19.1

Qtrly Rev. Growth

23.1

Gross Profit (p.s.)

2.707

Sales Per Share

EBITDA (p.s.)

-1.085

Qtrly Earnings Growth

Operating Cash Flow (M)

-118.90

Levered Free Cash Flow (M)

-62.64

atoplab.com

Valuation

P/E

-35.23

P/E Growth Ratio

P/BV

4.12

P/S

2328473600.00

P/CF

-66.08

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.